In this episode, Appleyard Lees partners, patent attorneys, and experienced opposition specialists, Bobby Smithson and Jennifer Delaney, give their outlook on patent oppositions and appeals at the EPO in 2022.
Read more
SPCs are national rights that apply to certain pharmaceutical and plant protection products that have been authorized for use by the regulatory authorities. Will they follow the introduction of the UP/UPC?
Read moreFor brand owners, in particular in the pharmaceutical field, one of the most difficult trade arenas to navigate can be the grey market. Our guide to the grey market, what it is and when brand owners can stop grey market goods is below.
Read more In this episode, Appleyard Lees partners and solicitors Bill Lister and Chris Hoole discuss the benefits of mediation vs. court proceedings, and how mediation in intellectual property cases can differ to non-intellectual property cases.
Read more
A number of Alternative Dispute Resolution (“ADR”) strategies have been developed over the last few decades. They can provide cost-effective alternatives to court proceedings, and allow two parties to negotiate a settlement in a confidential environment.
Read more
On 6 April 2022, after a high-stakes, eleven day trial, the High Court of England and Wales declared that Ed Sheeran, singer/songwriter, did not infringe copyright relating to the song “Oh Why” by Sami Chokri. The allegation that Ed Sheeran copied the catchy parts of “Oh Why” was therefore dismissed by the Court.
Read more
It appears that the EPO will stay proceedings in cases where the assessment of inventive step is exclusively reliant on whether post-published evidence can be taken into consideration.
Read more
“Damages inquiries are rare in intellectual property cases”. Fortunately, every now and again, a case is heard on inquiry, providing practitioners and rights holders with a practical refresher on the calculation of damages in UK proceedings.
Read more
The Unitary Patent (UP) and the Unified Patent Court (UPC) go live on 1 June 2023, when the UPC Agreement (UPCA) enters into force.
Read more partner David Walsh, and senior associates Chris Mason and Paul Beynon discuss key insights from the report, and the complexities of analysing patent data.
Read more Following a 2021 Board of Appeal decision, patent applications cannot be refused on the grounds that the description describes something that is not (or no longer) claimed.
Read more
